The Liver Meeting 2024 Research: Cirrhosis Presentation by Arun J. Sanyal, MBBS, MD

Co-chair of the TARGET-NASH steering committee, Arun J. Sanyal, MBBS, MD, helped author a new Target RWE study which was presented at AASLD 2024 titled, “A prospective assessment of the impact of decompensation of cirrhosis on patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease.”

This study explores the impact of cirrhosis decompensation on patient-reported outcomes, using data from the TARGET-NASH cohort. We will discuss the changes in health-related quality of life and functional status experienced by patients as their liver disease progresses. View Dr. Sanyal's video presentation.